NL-OMON30497尚未招募2 期
Danaparoid dosing during continuous venovenous hemofiltration - a randomized controlled pilot study investigating two danaparoid dosing schemes with a standard heparin dosing scheme - Danaparoid CVVH trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Critically ill patients with acute renal failure, needing CRRT.
排除标准
- •-No informed consent
- •-Use of unfractionated heparin or low molecular weight heparin in therapeutic doses within 24 hours before enrollment
- •-Extreme coagulation disorders, such as platelet count < 30 x 109/l, PT > 20 sec or APTT > 80 sec.
研究者
相似试验
已完成
4 期
Continuous veno-venous hemodialysis with citrate anticoagulation using a dedicated dialysatePatients 20 years of age or older for whom continuous hemodialysis is determined to be necessaryJPRN-UMIN000014911Intensive Care Unit, Department of Anesthesiology, Jikei University School of Medicine10
尚未招募
不适用
Anticoagulation with nadroparin in continuous venovenous hemofiltration (CVVH): extracorporeal clearance and systemic effects of nadropari(anti)stollingacute renal failurerenal replacement therapy10038430NL-OMON29873Onze Lieve Vrouwe Gasthuis30
已完成
1 期
Continuous intravenous adrenomedullin therapy for patients with inflammatory bowel disease (ulcerative colitis and Crohn's disease)inflammatory bowel disease (ulcerative colitis and Crohn's disease)JPRN-UMIN000021421First Department of Internal Medicine, Faculty of Medicine, University of Miyazaki10
已完成
2 期
Alternative therapy using continuous intravenous administration of adrenomedullin for patients with inflammatory bowel diseaseinflammatory bowel diseaseJPRN-UMIN000003230First Department of Internal Medicine, Faculty of Medicine, University of Miyazaki10
已完成
不适用
iver Citrate Anticoagulation Threshold studyISRCTN92716512Fresenius Medical Care (Germany)120